医学
糖尿病
胰高血糖素样肽-1
减肥
胰高血糖素样肽1受体
艾塞那肽
内科学
内分泌学
胰高血糖素
兴奋剂
受体
2型糖尿病
胰岛素
肥胖
作者
Areesha Moiz,Kristian B. Filion,Helia Toutounchi,Michael A. Tsoukas,Oriana Hoi Yun Yu,Tricia M. Peters,Mark J. Eisenberg
标识
DOI:10.7326/annals-24-01590
摘要
Recent randomized controlled trials (RCTs) have investigated glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual or triple co-agonists for weight loss among adults with overweight or obesity and without diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI